Nutriband (NTRB)

• Market cap: $56.9M
• 1 day: 1.39%
• 5 days: 4.92%
• 1 month: -23.92%
• 3 months: -1.73%
• 6 months: -19.12%
• Year to date: 12.53%
• 1 year: 44.63%
• 5 years: -10.65%
• 10 years: -10.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Employees: 3

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.3% less ownership

Funds ownership: 2.5% [Q3] → 2.2% (-0.3%) [Q4]

13% less funds holding

Funds holding: 15 [Q3] → 13 (-2) [Q4]

31% less capital invested

Capital invested by funds: $1.68M [Q3] → $1.16M (-$521K) [Q4]

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $13 154% upside
• Avg. target: $13 154% upside
• High target: $13 154% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Noble Capital Markets Robert LeBoyer 0% 1-year accuracy 0 / 3 met price target

154% upside $13

Outperform Initiated

22 Jan 2025